Authors' reply

Song Tao Timothy Cheo¹, Keith Hsiu Chin Lim^{1

2}

Affiliations

¹ Department of Radiation Oncology, National Cancer Institute Singapore, National University Health System, Singapore.
² NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Comment

Song Tao Timothy Cheo et al. Singapore Med J. 2017 Apr.

. 2017 Apr;58(4):228.

doi: 10.11622/smedj.2017032.

Song Tao Timothy Cheo¹, Keith Hsiu Chin Lim^{1

2}

¹ Department of Radiation Oncology, National Cancer Institute Singapore, National University Health System, Singapore.
² NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

No abstract available

Comment on

Comment on: Glioblastoma multiforme outcomes of 107 patients treated in two local institutions.
Lange JH. Lange JH. Singapore Med J. 2017 Apr;58(4):227-228. doi: 10.11622/smedj.2017031. Singapore Med J. 2017. PMID: 28429030 Free PMC article. No abstract available.

1. Cheo ST, Lim GH, Lim KH. Glioblastoma multiforme outcomes of 107 patients treated in two local institutions. Singapore Med J. 2017;58:41–5. - PMC - PubMed
1. Lange JH. Comment on: Glioblastoma multiforme outcomes of 107 patients treated in two local institutions. Singapore Med J. 2017;58:227–8. - PMC - PubMed
1. Veliz I, Loo Y, Castillo O, et al. Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future? Ann Transl Med. 2015;3:7. - PMC - PubMed
1. Stupp R, Taillibert S, Kanner AA, et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314:2535–43. - PubMed